Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.



<ul>
<li>Keybanc analyst Bradley B. Thomas downgraded Purple Innovation Inc (NASDAQ:PRPL) from Overweight to Sector Weight. Purple Innovation shares closed at $0.53 on Tuesday. See how other analysts view this stock.</li>



<li>Barrington Research analyst Michael Petusky downgraded OPKO Health Inc (NASDAQ:OPK) from Outperform to Market Perform. OPKO Health shares closed at $1.21 on Tuesday. See how other analysts view this stock.</li>



<li>JP Morgan analyst Drew Levine downgraded Brown-Forman Corp (NYSE:BF.B) from Neutral to Underweight and cut the price target from $27 to $23. Brown-Forman shares closed at $27.73 on Tuesday. See how other analysts view this stock.</li>



<li>UBS analyst Kaio Prato downgraded MercadoLibre Inc (NASDAQ:MELI) from Buy to Neutral and cut the price target from $2,700 to $2,050. MercadoLibre shares closed at $1,791.99 on Tuesday. See how other analysts view this stock.</li>



<li>William Blair analyst Jonathan Ho downgraded Rapid7, Inc. (NASDAQ:RPD) from Outperform to Market Perform. Rapid7 shares closed at $5.82 on Tuesday. See how other analysts view this stock.</li>
</ul>



Considering buying PRPL stock? Here’s what analysts think: 



<figure class="wp-block-image size-large is-resized"><img width="1024" height="470" src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png"/></figure>



Photo via Shutterstock

PRPL

MELI

BF.B

Wall Street analysts have downgraded several stocks, including Purple Innovation (PRPL) from Overweight to Sector Weight, OPKO Health (OPK) from Outperform to Market Perform, Brown-Forman (BF.B) from Neutral to Underweight with a price target cut from $27 to $23, MercadoLibre (MELI) from Buy to Neutral with a price target reduction from $2,700 to $2,050, and Rapid7 (RPD) from Outperform to Market Perform. Analysts provided insights on these changes, reflecting a shift in market sentiment.

benzinga_article

Rapid7

Purple Innov

Mercadolibre

Opko Health

Brown-Forman-B

Brown-Forman

This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday